The emerging role of microRNAs in resistance to lung cancer treatments

MacDonagh, Lauren, Gray, Steven G., Finn, Stephen P., Cuffe, Sinead, O’Byrne, Kenneth J., & Barr, Martin P. (2015) The emerging role of microRNAs in resistance to lung cancer treatments. Cancer Treatment Reviews, 41(2), pp. 160-169.

View at publisher


One of the major challenges in the treatment of lung cancer is the development of drug resistance. This represents a major obstacle in the treatment of patients, limiting the efficacy of both conventional chemotherapy and biological therapies. Deciphering the mechanisms of resistance is critical to further understanding the multifactorial pathways involved, and in developing more specific targeted treatments. To date, numerous studies have reported the potential role of microRNAs (miRNAs) in resistance to various cancer treatments. MicroRNAs are a family of small non-coding RNAs that regulate gene expression by sequence-specific targeting of mRNAs causing translational repression or mRNA degradation. More than 1200 validated human miRNAs have been identified to date. While as little as one miRNA can regulate hundreds of targets, a single target can also be affected by multiple miRNAs. Evidence suggests that dysregulation of specific miRNAs may be involved in the acquisition of resistance to a number of cancer treatments, thereby modulating the sensitivity of cancer cells to such therapies. Therefore, targeting miRNAs may be an attractive strategy for developing novel and more effective individualized therapies, improving drug efficiency, and for predicting patient response to different treatments. In this review, we provide an overview on the role of miRNAs in resistance to current lung cancer therapies and novel biological agents.

Impact and interest:

28 citations in Scopus
24 citations in Web of Science®
Search Google Scholar™

Citation counts are sourced monthly from Scopus and Web of Science® citation databases.

These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.

Citations counts from the Google Scholar™ indexing service can be viewed at the linked Google Scholar™ search.

ID Code: 95328
Item Type: Journal Article
Refereed: Yes
Keywords: Micro RNA, resistance, lung cancer, chemotherapy, cancer therapies
DOI: 10.1016/j.ctrv.2014.12.009
ISSN: 0305-7372
Divisions: Current > Institutes > Institute of Health and Biomedical Innovation
Deposited On: 02 May 2016 22:57
Last Modified: 04 May 2016 00:57

Export: EndNote | Dublin Core | BibTeX

Repository Staff Only: item control page